Dare Bioscience, Inc. (DARE) › Capital ExpendituresDare Bioscience, Inc. (DARE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $180.0K2013: $7.0K2014: $225.0K2015: $277.0K2016: $535.0K2017: $02018: $11.8K2019: $02020: $17.6K2021: $14.5K2022: $63.1K2023: $629.4K2024: $573.0K2025: $385.3K$385.3K2012Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$385.3K-32.8%2024$573.0K-9.0%2023$629.4K+898.0%2022$63.1K+334.2%2021$14.5K-17.6%2020$17.6K—2019$0-100.0%2018$11.8K—2017$0-100.0%2016$535.0K+93.1%2015$277.0K+23.1%2014$225.0K+3114.3%2013$7.0K-96.1%2012$180.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share